We are pleased to announce that the Parkwalk Opportunities EIS Fund has participated in a £13m financing round into the AIM-listed Sphere Medical Holdings plc. The financing round was led by Woodford’s Patient Capital Trust plc and Chris Evans’ Arthurian Life Sciences Fund.

Sphere Medical is a dynamic company specialising in the development of innovative medical monitoring and diagnostic equipment.

Sphere’s products are used in a wide range of medical applications, enabling faster clinical decision-making and improved patient outcomes, whilst providing efficiencies that result in reduced healthcare costs.

Sphere Medical aims to improve patient care and reduce healthcare costs through supplying healthcare professionals with innovative, real time point of care diagnostic and monitoring products.